Content Syndication Downloads
Content Syndication Downloads are provided as a complimentary service by PentaVision LLC and its magazines. In submitting the registration form you agree to providing express consent to PentaVision LLC to share this contact information with the organization providing white papers that you download from this site.
Lutein has strong support for its role in ocular health and has recently been recognized for its cognition role during early life and childhood. This white paper looks at the evidence for lutein’s function in brain tissue, where it is the predominant carotenoid in both infants and adults. FloraGLO® Lutein is the only lutein brand approved for use in infant nutrition and the most clinically studied lutein brand in the world.
Response to supplementation with MacuHealth™ (a formulation consisting of meso-zeaxanthin [10 mg], lutein [10 mg] and zeaxanthin [2 mg]) was conducted by Moorfields Eye Hospital, London. The cohort of 49 subjects included those with non-advanced (n = 12) and advanced (n = 8) age-related macular degeneration, diabetic retinopathy with (n = 10) and without (n = 10) macular edema, central serous chorioretinopathy (n = 5) and no retinal disease (n = 4). By 6 months, statistically significant improvements in glare sensitivity (at low and medium spatial frequencies) were demonstrable, and reflected parallel statistically significant increases in macular pigment, prompting the investigators to conclude that supplementation with MacuHealth™ enhances visual performance and experience in healthy eyes and in eyes with a range of retinal diseases. These favorable observations by Moorfields Eye Hospital regarding the visual benefits of MacuHealth™ in diseased and in non-diseased eyes serve to replicate the findings of other investigators across the world.[2-4]
FloraGLO® Lutein sets the gold standard for the lutein market. Rooted in science, with an unparalleled reputation for efficacy, trust and safety, the FloraGLO® name is synonymous with excellence. “The Pioneers of Lutein Science and Discovery” offers the following:
- How researchers discovered the photoprotective properties of lutein and zeaxanthin;
- Why most adults aren’t getting enough in their diets; and
- How Kemin created a lutein supplement proven to increase macular pigment optical density (MPOD) in clinical trials.
Non-advanced age-related macular degeneration (AMD) does not profoundly affect vision, but is associated with gradual but relentless visual decline and, in many cases, progression to advanced and blinding AMD (atrophic and/or neovascular). Supplementation with antioxidants that include the macular carotenoids has been shown benefit patients with non-advanced AMD. A recent randomized, clinical trial has shown that a formulation containing all three macular carotenoids (in L:MZ:Z [mg] ratio of 10:10:2; MacuHealth with LMZ3 and MacuHealthPlus+ ) outperforms a MZ-deficient formulation in patients with non-advanced AMD, both in terms of visual improvements and in terms of observed increases in macular pigment.
Medical foods are an emerging category of product, formulated to address nutritional deficiencies relating to specific diseases or conditions. This whitepaper provides an insight into:
· The importance of targeted nutrition for eye health
· The medical food category: Guidelines, market size, regulations
· Macular pigment: Risk factor, biomarker, vision performance
· Lumega-Z: the first and only medical food developed to restore and maintain the macular pigment
Download the whitepaper to learn about this differentiated offering, and discover how to maximize the efficacy of your intervention, ensure patient compliance and satisfaction.